nitroxyl has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, G; Hauser, AD; Joseph, J; Kalyanaraman, B; Lopez, M; McAllister, D; Rowe, JJ; Sugg, SL; Williams, CL; Zielonka, J | 1 |
1 other study(ies) available for nitroxyl and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Drug Synergism; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Mevalonic Acid; Mitochondria; Nitrogen Oxides; Organophosphorus Compounds; Reactive Oxygen Species | 2011 |